Alternative administration of camptothecin analogues

Area of Science:

• Pharmacology
• Drug Delivery
• Oncology

Background:

• Camptothecin (CPT) derivatives exhibit anticancer activity through reversible binding to DNA-topoisomerase complexes.
• Maintaining the active lactone form of CPT is crucial for maximal inhibitory effect.
• The lactone form is unstable in human serum, favoring the carboxylate form, necessitating alternative administration strategies for CPT analogues.

Purpose of the Study:

• To evaluate alternative administration routes for camptothecin analogues to enhance drug stability and efficacy.
• To investigate the pharmacokinetic and safety profiles of novel drug delivery methods for CPT derivatives.

Main Methods:

• Oral administration of rubitecan was assessed, noting a low lactone to total drug ratio and plasma concentration.
• Aerosolized liposomal rubitecan was administered to patients, with plasma levels and lactone ratio monitored.
• Intrathecal and intraperitoneal administration of topotecan were studied in Phase I trials, evaluating toxicity and clinical responses.

Main Results:

• Oral rubitecan showed low lactone stability and plasma concentrations.
• Aerosolized liposomal rubitecan achieved higher plasma levels than oral administration, but with a low lactone ratio; no toxicity was observed.
• Intrathecal topotecan was tolerated in children with refractory meningeal carcinomatosis, showing clinical responses.
• Intraperitoneal topotecan demonstrated dose-limiting toxicities (neutropenia, anemia) but provided symptomatic relief in patients with ascites, with a high peritoneal to plasma AUC ratio.

Conclusions:

• Alternative administration routes for camptothecin analogues are critical for improving therapeutic outcomes.
• Aerosolized liposomal rubitecan and intrathecal/intraperitoneal topotecan show promise but require further investigation regarding lactone stability and optimal dosing.
• Further studies are warranted to optimize delivery and maximize the therapeutic potential of camptothecin derivatives through various administration routes.